Welcome to the Inflammatory Bowel Disease Resource Centre. The Resource Centre provides you with free access to the latest peer-reviewed clinical information relating to the treatment of IBD, together with insights and opinions from key thought leaders.
All content on this platform is reviewed and collated by the Resource Centre’s editor, Dr Alessandro Armuzzi: “IBD can really affect people’s lives, and as healthcare professionals we can help limit the impact the disease has on them by treating it as effectively as possible. We hope that this resource will give healthcare professionals the information and guidance they need to help people with the disease.”
This resource is provided by the journal Digestive and Liver Disease, published by Elsevier, and made possible by an educational grant from Ferring
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease
Paolo Gionchetti , Fernando Rizzello , Vito Annese , Alessandro Armuzzi , Livia Biancone , Fabiana Castiglione , Michele Comberlato , Mario Cottone , Silvio Danese , Marco Daperno , Renata D’Incà , Walter Fries , Anna Kohn , Ambrogio Orlando , Claudio Papi , Maurizio Vecchi , Sandro Ardizzone Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Digestive and Liver Disease, June 2017, Volume 49, Issue 6, Pages 604-617
Pediatric-onset inflammatory bowel disease poses risk for low bone mineral density at early adulthood
Anat Guz-Mark , Firas Rinawi , Oxana Egotubov , Ilan Shimon , Raanan Shamir , Amit AssaDigestive and Liver Disease, June 2017, Volume 49, Issue 6, Pages 639-642
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease
Sonja Milovanovic , Franco Scaldaferri , Stefania Canarecci , Flavia Kheiraoui , Giulia Ciancarella , Chiara de Waure , Agnese Collamati , Elisa Schiavoni , Antonio Gasbarrini , Stefania Boccia , Andrea PosciaDigestive and Liver Disease, Available online 5 July 2017
Laurent BeaugerieProf. Beaugerie states that immunosurveillance is essential in IBD patients with recently successfully treated cancer, and the use of immunosuppressants...
Philip RosenstielPhilip Rosenstiel asks: can we understand the microbiome and the inflammatory response? He explores the concept that diet and microbiota...
Filip BaertFilip Baert is posed the question: should we de-escalate or stop treatment for patients with IBD in remission? He argues...
Silvio Danese (Chair), Axel Dignass, Edouard LouisSponsored symposium by Ferring Pharmaceuticals at the 11th Congress of the European Crohn’s and Colitis Organisation, Amsterdam, 2016
Axel DignassSponsored symposium by Ferring Pharmaceuticals at the 11th Congress of the European Crohn’s and Colitis Organisation, Amsterdam, 2016
Edouard LouisSponsored symposium by Ferring Pharmaceuticals at the 11th Congress of the European Crohn’s and Colitis Organisation, Amsterdam, 2016